Michael A. Sweetland

2.4k total citations · 1 hit paper
16 papers, 2.1k citations indexed

About

Michael A. Sweetland is a scholar working on Surgery, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael A. Sweetland has authored 16 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Physiology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael A. Sweetland's work include Nitric Oxide and Endothelin Effects (7 papers), Pancreatic function and diabetes (7 papers) and Diet, Metabolism, and Disease (6 papers). Michael A. Sweetland is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Pancreatic function and diabetes (7 papers) and Diet, Metabolism, and Disease (6 papers). Michael A. Sweetland collaborates with scholars based in United States. Michael A. Sweetland's co-authors include Jack R. Lancaster, John A. Corbett, Michael L. McDaniel, Jaw‐Lin Wang, Joseph R. Williamson, Yasuo Ido, Ronald G. Tilton, Kathy Chang, Khalid S. Hasan and Mauricio Di Silvio and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Michael A. Sweetland

16 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction

1992 526 citations John A. Corbett, Ronald G. Tilton et al. Diabetes profile →

Peers

Countries citing papers authored by Michael A. Sweetland

Since Specialization

Citations

This map shows the geographic impact of Michael A. Sweetland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Sweetland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Sweetland more than expected).

Fields of papers citing papers by Michael A. Sweetland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Sweetland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Sweetland. The network helps show where Michael A. Sweetland may publish in the future.

Co-authorship network of co-authors of Michael A. Sweetland

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Sweetland. A scholar is included among the top collaborators of Michael A. Sweetland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Sweetland. Michael A. Sweetland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Myeloperoxidase-catalyzed redox-cycling of phenol promotes lipid peroxidation and thiol oxidation in HL-60 cells 1999 ·Free Radical Biology and Medicine ·Radoslav Goldman, (unknown), Michael A. Sweetland, (unknown), Vladimir A. Tyurin, Elena R. Kisin, Yulia Y. Tyurina, Vladimir B. Ritov, Sharon L. Wenger, Stephen G. Grant, Valerian E. Kagan	51
2	A reversible NO complex of FeII(TIM): an nitrosyl 1997 ·Inorganica Chimica Acta ·Chen Ya, Michael A. Sweetland, Rex E. Shepherd⊛	17
3	Ligand field factors in promoting S = 32 {FeNO}7 nitrosyls 1997 ·Journal of Inorganic Biochemistry ·Rex E. Shepherd⊛, Michael A. Sweetland, (unknown)	30
4	NO-Redox Paradox: Direct Oxidation of α-Tocopherol and α-Tocopherol-Mediated Oxidation of Ascorbate 1996 ·Biochemical and Biophysical Research Communications ·Nikolai V. Gorbunov, А. N. Оsipov, Michael A. Sweetland, Billy W. Day, Nabil M. Elsayed, Valerian E. Kagan	23
5	Hepatocyte inducible nitric oxide synthesis is influenced in vitro by cell density 1994 ·American Journal of Physiology-Cell Physiology ·Andreas K. Nüssler, (unknown), Mauricio Di Silvio, Michael A. Sweetland, David A. Geller, Jack R. Lancaster, Timothy R. Billiar, Paul D. Freeswick, (unknown), Richard L. Simmons	32
6	Nitric oxide generation following intrahepatic human-to-rat islet transplantation is blocked by NG-monomethyl-L-arginine. 1994 ·PubMed ·R. Behboo, Jack R. Lancaster, Michael A. Sweetland, (unknown), Robert P. Hoffman, Richard L. Simmons, Camillo Ricordi	2
7	Nonheme Iron-Nitrosyl Complex Formation in Rat Hepatocytes: Detection by Electron Paramagnetic Resonance Spectroscopy 1993 ·Archives of Biochemistry and Biophysics ·J. Stadler, Hector A. Bergonia, Mauricio Di Silvio, Michael A. Sweetland, Timothy R. Billiar, R L Simmons, Jack R. Lancaster	95
8	Induction of Nitric Oxide Synthesis and Its Reactions in Cultured Human and Rat Hepatocytes Stimulated with Cytokines Plus LPS 1993 ·Biochemical and Biophysical Research Communications ·Andreas K. Nüssler, David A. Geller, Michael A. Sweetland, Mauricio Di Silvio, Timothy R. Billiar, (unknown), Richard L. Simmons, Jack R. Lancaster	76
9	A 1‐hour pulse with IL‐1β induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism 1993 ·The FASEB Journal ·John A. Corbett, Michael A. Sweetland, Jack R. Lancaster, Michael L. McDaniel	63
10	Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. 1993 ·Proceedings of the National Academy of Sciences ·John A. Corbett, Michael A. Sweetland, Jaw‐Lin Wang, Jack R. Lancaster, Michael L. McDaniel	353
11	Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. 1992 ·Journal of Clinical Investigation ·John A. Corbett, Jaw‐Lin Wang, Michael A. Sweetland, Jack R. Lancaster, Michael L. McDaniel	254
12	Nitric oxide and cyclic GMP formation induced by interleukin 1β in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction 1992 ·Biochemical Journal ·John A. Corbett, Jaw‐Lin Wang, Jonathan H. Hughes, Bryan A. Wolf, Michael A. Sweetland, Jack R. Lancaster, Michael L. McDaniel	129
13	Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction breakdown → 1992 ·Diabetes ·John A. Corbett, Ronald G. Tilton, Kathy Chang, Khalid S. Hasan, Yasuo Ido, (unknown), Michael A. Sweetland, Jack R. Lancaster, Joseph R. Williamson, Michael L. McDaniel	526
14	Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction 1992 ·Diabetes ·John A. Corbett, Ronald G. Tilton, (unknown), (unknown), Yasuo Ido, (unknown), Michael A. Sweetland, (unknown), Joseph R. Williamson, Michael L. McDaniel	151
15	Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. 1991 ·Journal of Biological Chemistry ·John A. Corbett, Jack R. Lancaster, Michael A. Sweetland, Michael L. McDaniel	232
16	Electron-transfer kinetics of chlorotetrakis(p-chlorophenyl)porphinatomanganese(III) in dimethyl sulfoxide-imidazole mixtures 1978 ·Inorganic Chemistry ·Karl M. Kadish, Michael A. Sweetland, Jun Cheng	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact